Upacicalcet sodium structure
|
Common Name | Upacicalcet sodium | ||
---|---|---|---|---|
CAS Number | 2052969-18-1 | Molecular Weight | 373.75 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C11H13ClN3NaO6S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Upacicalcet sodiumUpacicalcet sodium is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1]. |
Name | Upacicalcet sodium |
---|
Description | Upacicalcet sodium is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1]. |
---|---|
Related Catalog | |
Target |
calcium-sensing receptors[1] |
References |
[1]. Hoy SM. Upacicalcet: First Approval. Drugs. 2021;81(13):1593-1596. |
Molecular Formula | C11H13ClN3NaO6S |
---|---|
Molecular Weight | 373.75 |